Ferric Oxyhydroxide Global Patent Coverage & Expiry Overview

Track protection status across key markets to assess launch feasibility.

It is formulated by 3 pharmaceutical companies such as HIKMA, AM REGENT, VIFOR FRESENIUS. It is marketed under 3 brand names, including SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSE, VENOFER, VELPHORO. Available in 3 different strengths, such as EQ 62.5MG IRON/5ML (EQ 12.5MG IRON/ML), EQ 65MG IRON/3.25ML (EQ 20MG IRON/ML), EQ 500MG IRON, and administered through 3 routes including INJECTABLE;INJECTION, INJECTABLE;INTRAVENOUS, TABLET, CHEWABLE;ORAL.

Strategic Dashboard

info

insightsStrategic Insights

Sourcing & Feasibility

check_circle API availability: autorenew Loading API feasibility...

groups Licensing: 3 potential partners

calendar_todayUS Launch window: autorenew Loading launch window...

timeline Key Patent Barrier & Expiry Timeline

autorenew Loading patent barriers...

factoryGeneric Manufacturer Snapshot

autorenew Loading manufacturers...

gavelRisk & Opportunity Summary

dangerous Risk: autorenew Loading risk analysis...
watch_later Watch: autorenew Loading watch analysis...
rocket_launch Opportunity: autorenew Loading opportunity analysis...
flag
gavel
calendar_today
calendar_today

Access Global Patent Data

Stay ahead with worldwide patent expiry and latest updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
Unlock Global Patents

Orange Book Drug Approval Timeline

FDA approval history for this ingredient

NDA (New Drug Application) ANDA (Generic Application)

Access Global Exclusivity and Patent Expiry Extensions

Stay ahead with worldwide patent expiry insights, exclusivity data, and latest updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
✓ Latest exclusivity data and extensions
Unlock Global Access

US Orange Book Patents Expiration Timeline

Key expiration dates for US patents covering this ingredient

View Global Patents Expiration Timeline

Stay ahead with worldwide patent expiry insights, market data, and research updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
Unlock Global Patent Timeline

Orange Book Drug Strengths

Latest drug strengths approved by FDA

Strength Route of Administration Companies Latest Approval Date

Orange Book Patents

Patents approved by the FDA for the ingredient

Patent Number Publication Date Legal Status Patent Expiry Date
{"application_id":"84051","ingredient":"FERRIC OXYHYDROXIDE","trade_name":"VELPHORO","family_id":"0b359db020b04b84bfcf","publication_number":"US11013762B2","cleaned_patent_number":"11013762","drug_product_flag":"-, Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-05-13","publication_date":"2021-05-25","legal_status":"Patented case"} US11013762B2 25 May, 2021 Patented case 13 May, 2029
{"application_id":"84044","ingredient":"FERRIC OXYHYDROXIDE","trade_name":"VELPHORO","family_id":"0b359db020b04b84bfcf","publication_number":"US10682376B2","cleaned_patent_number":"10682376","drug_product_flag":"-, Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-05-13","publication_date":"2020-06-16","legal_status":"Granted"} US10682376B2 16 Jun, 2020 Granted 13 May, 2029
{"application_id":"84045","ingredient":"FERRIC OXYHYDROXIDE","trade_name":"VELPHORO","family_id":"0b359db020b04b84bfcf","publication_number":"US10695367B2","cleaned_patent_number":"10695367","drug_product_flag":"-, Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-05-13","publication_date":"2020-06-30","legal_status":"Granted"} US10695367B2 30 Jun, 2020 Granted 13 May, 2029
{"application_id":"84047","ingredient":"FERRIC OXYHYDROXIDE","trade_name":"VELPHORO","family_id":"0b359db020b04b84bfcf","publication_number":"US10925896B2","cleaned_patent_number":"10925896","drug_product_flag":"-, Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-05-13","publication_date":"2021-02-23","legal_status":"Patented case"} US10925896B2 23 Feb, 2021 Patented case 13 May, 2029
{"application_id":"84048","ingredient":"FERRIC OXYHYDROXIDE","trade_name":"VELPHORO","family_id":"0b359db020b04b84bfcf","publication_number":"US10925897B2","cleaned_patent_number":"10925897","drug_product_flag":"-, Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-05-13","publication_date":"2021-02-23","legal_status":"Granted"} US10925897B2 23 Feb, 2021 Granted 13 May, 2029
{"application_id":"84049","ingredient":"FERRIC OXYHYDROXIDE","trade_name":"VELPHORO","family_id":"0b359db020b04b84bfcf","publication_number":"US10933090B2","cleaned_patent_number":"10933090","drug_product_flag":"-, Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-05-13","publication_date":"2021-03-02","legal_status":"Granted"} US10933090B2 02 Mar, 2021 Granted 13 May, 2029
{"application_id":"84050","ingredient":"FERRIC OXYHYDROXIDE","trade_name":"VELPHORO","family_id":"0b359db020b04b84bfcf","publication_number":"US11013761B2","cleaned_patent_number":"11013761","drug_product_flag":"-, Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-05-13","publication_date":"2021-05-25","legal_status":"Patented case"} US11013761B2 25 May, 2021 Patented case 13 May, 2029
{"application_id":"83976","ingredient":"FERRIC OXYHYDROXIDE","trade_name":"VELPHORO","family_id":"0b359db020b04b84bfcf","publication_number":"US9561251B2","cleaned_patent_number":"9561251","drug_product_flag":"-, Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-07-23","publication_date":"2017-02-07","legal_status":"Granted"} US9561251B2 07 Feb, 2017 Granted 23 Jul, 2030
{"application_id":"83946","ingredient":"FERRIC OXYHYDROXIDE","trade_name":"VELPHORO","family_id":"b5859918eb814a9c92c4","publication_number":"US11234938B2","cleaned_patent_number":"11234938","drug_product_flag":"-, Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-05-26","publication_date":"2022-02-01","legal_status":"Granted"} US11234938B2 01 Feb, 2022 Granted 26 May, 2035
{"application_id":"83971","ingredient":"FERRIC OXYHYDROXIDE","trade_name":"VELPHORO","family_id":"6d543f13e8a340a19ce9","publication_number":"US11446252B2","cleaned_patent_number":"11446252","drug_product_flag":"-, Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-05-26","publication_date":"2022-09-20","legal_status":"Granted"} US11446252B2 20 Sep, 2022 Granted 26 May, 2035
{"application_id":"83968","ingredient":"FERRIC OXYHYDROXIDE","trade_name":"VELPHORO","family_id":"b5859918eb814a9c92c4","publication_number":"US10624855B2","cleaned_patent_number":"10624855","drug_product_flag":"-, Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-05-26","publication_date":"2020-04-21","legal_status":"Granted"} US10624855B2 21 Apr, 2020 Granted 26 May, 2035

Recent Clinical Trials

Latest clinical trials and research studies for this ingredient

NCT ID Title Status Phase Conditions Start Date Completion Date

API Suppliers/Manufacturer (Branded/Generic companies)

Manufacturing Locations

View Complete Supplier List

Unlock access to all suppliers of Ferric Oxyhydroxide

✓ Access a comprehensive list of global suppliers
✓ Get information on each supplier
Unlock Suppliers

Note: Patent expirations and exclusivity timelines are dynamic and may shift based on litigation, regulatory extensions, and maintenance filings. Regular monitoring is advised.

GreyB © 2025 Elixir. All rights reserved.